# Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke

> **NCT05282290** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Stroke Patients

## Interventions

- **DRUG:** Antihypertensive drugs (no restriction on the type of drugs)

## Key facts

- **NCT ID:** NCT05282290
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-22
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282290, "Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05282290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*